Search results

An AI health-tech startup recently named one of the world's most promising had its roots in the re-organisation of Xerox's research centre in India

In a Delaware case Boehringer Ingelheim accuses the Illinois company of improper conduct in deliberately constructing a patent thicket to protect against generic versions of its blockbuster drug.

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco 

The telecoms giant is building its presence in the secondary market with a host of companies now seeking out its high-quality patents  

An annual survey conducted by CNIPA pegs the licensing rate of Chinese patents at 5.5%. That's not far off estimates of US patent utilisation

Former IV unit teams up with alternative asset business to give large and small innovators way of attracting finance on Blockchain-based initiative

The settlement deal ends litigation by the Singapore company’s ZiiLabs unit against Nvidia, and will net shareholders around $17.5 million

Deep pockets, a strong commitment to R&D and a world class 5G patent portfolio mean that whatever its current difficulties the Chinese telecoms business is set to be a major player for the long term

The high-end maker of tablets and styluses for artists and designers makes its latest patent acquisition amidst new US litigation and a push to reach more consumers with competitively priced offerings

If the Commission and Apple are successful in rewriting the rules for chipmaker's licensing arm beware of unintended consequences that reduce choice and harm consumers, expert analyst states

Sell-off continues as new ownership seeks to get out from under nearly $100 million in debt with just a few hundred granted US patents remaining in its arsenal

The newest members of IAM's IP Asia Elite give us the inside scoop on what makes a great IP function tick  

The annual search for outstanding individuals to induct into the IP Hall of Fame starts today and we want your help.

Chaya Chandavasu, senior vice president for science and innovation at PTT Global Chemical, explains how IP strategy has helped the subsidiary of Thailand's state-owned oil and gas giant better understand its technology space and attract joint venture partners

The Federal Circuit’s precedential judgment in Supernus Pharmaceuticals v Iancu is good news for rights holders – especially those in life sciences